Business Strategy

Aptahem’s strategy is to take drug candidates through early development phase and find license or collaboration partners for late development phase and market approval.

The goal with entering partnership or license agreements is to generate resources to promote the company’s portfolio of drug candidates and to strengthen the company’s value. With the drug candidate Apta-1, the company aims at entering such an agreement in early clinical phase.